1. Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
- Author
-
Virginia Urquidi, Steve Goodison, Shanti Ross, Evan Gomes-Giacoia, Ge Zhang, Charles J. Rosser, Makito Miyake, Jeongsoon Kim, and Adrienne Lawton
- Subjects
Adult ,Male ,Chemokine ,Cancer Research ,Chemokine CXCL1 ,animal diseases ,Biomarkers, Tumor ,Genetics ,Medicine ,CXCL10 ,Humans ,CXCL13 ,Chemokine Ligand 1 (CXCL1) ,Aged ,Neoplasm Staging ,Aged, 80 and over ,Carcinoma, Transitional Cell ,Bladder cancer ,biology ,business.industry ,Tumor Stage ,Middle Aged ,Tumor Grade ,respiratory system ,medicine.disease ,Immunohistochemistry ,Bladder Cancer ,CXCL1 ,Urinary Bladder Neoplasms ,Oncology ,biology.protein ,Cancer research ,CCL27 ,Female ,business ,CCL21 ,Research Article - Abstract
Background Chemokines, including chemokine (C-X-C motif) ligand 1 (CXCL1), may regulate tumor epithelial-stromal interactions that facilitate tumor growth and invasion. Studies have linked CXCL1 expression to gastric, colon and skin cancers, but limited studies to date have described CXCL1 protein expression in human bladder cancer (BCa). Methods CXCL1 protein expression was examined in 152 bladder tissue specimens (142 BCa) by immunohistochemical staining. The expression of CXCL1 was scored by assigning a combined score based on the proportion of cells staining and intensity of staining. CXCL1 expression patterns were correlated with clinicopathological features and follow-up data. Results CXCL1 protein expression was present in cancerous tissues, but was entirely absent in benign tissue. CXCL1 combined immunostaining score was significantly higher in high-grade tumors relative to low-grade tumors (p = 0.012). Similarly, CXCL1 combined immunostaining score was higher in high stage tumors (T2-T4) than in low stage tumors (Ta-T1) (p Conclusion To date, this is the largest study describing increased CXCL1 protein expression in more aggressive phenotypes in human BCa. Further studies are warranted to define the role CXCL1 plays in bladder carcinogenesis and progression.
- Full Text
- View/download PDF